According to the Official Journal of the European Union, on July 11, 2024, the European Commission issued Regulation (EU) No. 2024/1892, extending the approval period for four active substances such as amisulbrom, which will enter into force on the 20th day from the date of publication.

According to the regulations, the approval period for S-abscisic acid and amisulbrom was extended until September 15, 2026.

The approval period for valifenalate and thiencarbazone has been extended to March 1, 2027.

According to the Official Journal of the European Union, on July 11, 2024, the European Commission issued Regulation (EU) No. 2024/1892, extending the approval period for four active substances such as indazolsulfamide, which will enter into force on the 20th day from the date of publication.